Sponsor hub
Rutgers, The State University of New Jersey clinical trial failures
Review 45 stopped clinical trials from Rutgers, The State University of New Jersey, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 1 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 29
- OTHER/UNKNOWN
- 15
- EFFICACY/FUTILITY
- 1
Notable sponsors
- Rutgers, The State University of New Jersey
- 45
Related phases
- Phase II
- 20
- Phase IV
- 8
- Phase I
- 7
- Unknown
- 5
- Early Phase I
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 45 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase IV Transformed Migraine trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
no patients during covid pandemic
Phase II Pain, Postoperative trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
This study never got funded. It is not feasible to conduct this study without funding.
Phase IV Recovery Following Cholecystectomy trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
The study was halted due to the worldwide COVID-19 pandemic and the cancellation of all elective cases.
Phase II Pancreatic Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
No patients enrolled
Phase I Refractory Lung Non-Small Cell Carcinoma trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
accrual goal met
Phase II High Grade B-Cell Lymphoma, Not Otherwise Specified trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
This study was never submitted to the IRB for review and approval. No research subjects were enrolled. .
Phase I Locally Advanced Skin Squamous Cell Carcinoma trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
slow accrual
Phase II Cancer of Rectum trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
no slots available
Phase IV Pain Management trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
Terminated after 8 participants as prospect for funded is no longer viable
Phase I Lung Cancer Stage III trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
The research was cancelled
Phase IV COPD trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Lack of research staff to recruit participants
Phase II Prostate Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
slow accrual
Phase I Prostate Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Slow accrual
Phase IV Gout Attack trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
The Sponsor has decided to stop funding this study due to lack of enrollment during COVID-19 pandemic and decreased interest in funding investigator initiated studies pertaining to the study drug
Phase I Breast Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Closed early due to slow accrual
Phase II Metastatic Melanoma trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
Study Complete
Early Phase I Acute Lymphoblastic Leukemia trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Lack of enrollment
Phase III Postdural Puncture Headache trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
no enrollment after covid pandemic
Phase II Breast Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Slow accrual
Phase II SARS-CoV-2 trial by Rutgers, The State University of New Jersey. Stop reason: EFFICACY/FUTILITY.
Ineffectiveness of treatment
Phase II Recurrent Prostate Carcinoma trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Slow accrual
Phase I Unspecified Adult Solid Tumor - Protocol Specific trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Ovarian Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
Research cancelled
Phase II SARS-CoV Infection trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
Lack of participants willing to enroll
Early Phase I Clear Cell Renal Cell Carcinoma trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Funding unavailable
Unknown Adult Acute Megakaryoblastic Leukemia (M7) trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
No patients were eligible to receive the experimental component of the protocol therapy.
Phase II Kidney Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Slow accrual
Unknown Stage III Squamous Cell Carcinoma of the Hypopharynx trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Slow accrual
Phase II Joint Prosthesis trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
PI left the institute and the funding expired.
Phase IV Degenerative Arthritis and Postoperative Pain trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
No longer able to recruit subjects due to unavailability of orthopedic surgeon.
Phase II SARS-CoV-2 Infection trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
The investigators have decided not to go forward with this protocol
Phase II Healthy Subject trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Principal Investigator Decided to stop recruitment in the trial.
Phase III Portal Hypertension Related to Cirrhosis trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
We need to revise and redesign the study
Phase II Healthy trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Principal Investigator left institution before study could complete.
Phase II Vitiligo trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
Principal investigator made the decision to close study and not submit a renewal. Lack of fixed research personnel to carry out the study effectively.
Phase II Shock trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
PI's add. responsibilities and time commitment prevent him from completing trial
Unknown Atopic Dermatitis trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Lack of response to recruitment
Phase II Prostate Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
The Investigator left the organization.
Unknown Graft Versus Host Disease trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
slow accrual
Phase IV Depression, Myalgia trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
unable to increase to target enrollment
Phase II Breast Cancer trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Liver Disease trial by Rutgers, The State University of New Jersey. Stop reason: OTHER/UNKNOWN.
We no longer had an appropriate patient population.Study closed
Early Phase I Prostate Carcinoma trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
slow accrual
Phase II Leukemia trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
Study was terminated early due to lack of experimental medication (supply issues)
Phase IV Orthopedic/Podiatry Procedures trial by Rutgers, The State University of New Jersey. Stop reason: OPERATIONAL.
unable to secure funding for analysis of laboratory data.